SALT LAKE CITY, - Myriad Pharmaceuticals, Inc. (Nasdaq:MYRX), a company focused on discovering, developing and commercializing novel, small molecule drugs for the treatment of cancer and HIV infection, today announced that Adrian N. Hobden, President and CEO of Myriad Pharmaceuticals, will provide an overview of the Company at the following conferences:
* Rodman & Renshaw 11th Annual Healthcare Conference on September 11, 2009 at 10:25 a.m. ET at the New York Palace Hotel in New York City.
* The 16th Annual Newsmakers in the Biotech Industry Conference on September 16, 2009 at 10:00 a.m. ET at the Millennium Broadway Hotel and Conference Center in New York City.
* UBS Global Life Sciences Conference on September 21, 2009 at 11:30 a.m. ET at the Grand Hyatt Hotel in New York City.
No comments:
Post a Comment